MediGene AG (MDGEF)

0.10 0.00 (0.00%) USD  |  OTCM  |  Oct 15, 16:00
More

MediGene Cash from Operations (TTM)

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2024 -15.32M
December 31, 2023 -16.34M
June 30, 2023 -14.08M
December 31, 2022 13.50M
Date Value
June 30, 2022 14.98M
December 31, 2021 -12.81M
June 30, 2021 -20.04M
December 31, 2020 -28.05M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
InflaRx NV -32.60M
BioNTech SE 725.62M
Immatics NV -241.73M
Arrowhead Pharmaceuticals, Inc. -59.06M
Oncolytics Biotech, Inc. -26.52M